View in EDS HTML Full Text PDF Full Text

Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment?

Saved in:
Bibliographic Details
Title: Stromal PDGFR-beta expression is a prognostic factor in high-grade serous ovarian cancer patients but is it also predictive for response to antiangiogenic treatment?
Authors: Volk A; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany. an.volk@uke.de., von Bülow C; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Stern A; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.; Department of Internal Medicine, Southwest Healthcare, Temecula, USA., Simon R; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Burandt E; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Sauter G; Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schmalfeldt B; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany., Oliveira-Ferrer L; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2025 Jan 24; Vol. 151 (2), pp. 44. Date of Electronic Publication: 2025 Jan 24.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1432-1335
DOI:10.1007/s00432-025-06090-4